Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IFOSFAMIDE Cause Toxicity to various agents? 325 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 325 reports of Toxicity to various agents have been filed in association with IFOSFAMIDE (IFEX). This represents 1.9% of all adverse event reports for IFOSFAMIDE.

325
Reports of Toxicity to various agents with IFOSFAMIDE
1.9%
of all IFOSFAMIDE reports
106
Deaths
68
Hospitalizations

How Dangerous Is Toxicity to various agents From IFOSFAMIDE?

Of the 325 reports, 106 (32.6%) resulted in death, 68 (20.9%) required hospitalization, and 37 (11.4%) were considered life-threatening.

Is Toxicity to various agents Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 325 reports have been filed with the FAERS database.

What Other Side Effects Does IFOSFAMIDE Cause?

Off label use (2,281) Febrile neutropenia (2,225) Disease progression (1,912) Neutropenia (1,509) Drug ineffective (1,331) Thrombocytopenia (1,227) Anaemia (1,067) Product use in unapproved indication (890) Pyrexia (752) Sepsis (712)

What Other Drugs Cause Toxicity to various agents?

OXYCODONE (17,518) ACETAMINOPHEN (16,128) FENTANYL (15,546) MORPHINE (15,337) BUPRENORPHINE (10,906) HYDROMORPHONE (10,769) HYDROCODONE (10,645) ACETAMINOPHEN\OXYCODONE (10,568) ACETAMINOPHEN\HYDROCODONE (10,343) TAPENTADOL (9,617)

Which IFOSFAMIDE Alternatives Have Lower Toxicity to various agents Risk?

IFOSFAMIDE vs IGURATIMOD IFOSFAMIDE vs ILOPERIDONE IFOSFAMIDE vs ILOPROST IFOSFAMIDE vs IMATINIB IFOSFAMIDE vs IMBRUVICA

Related Pages

IFOSFAMIDE Full Profile All Toxicity to various agents Reports All Drugs Causing Toxicity to various agents IFOSFAMIDE Demographics